Generated by AI
Gossamer Bio Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for pulmonary and inflammatory diseases. Its lead product candidate, seralutinib, is being studied for pulmonary hypertension, including pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease. The company also works on other drug candidates for immune-driven and respiratory conditions, using an approach centered on discovering and advancing targeted treatments. Gossamer Bio Inc. plays a specialized role in the healthcare market by addressing serious diseases with significant unmet medical need through its research, development, and clinical trial programs. The company is headquartered in San Diego, California.
Website3115 Merryfield Row
San Diego, CA, 92121
United States
The latest articles about GOSS.
Tipranks Press Release.
Summary of Nov 18's posts. Generated by AI.
Summary of Aug 27's posts. Generated by AI.
Summary of Dec 7's posts. Generated by AI.
Summary of Sep 11's posts. Generated by AI.
Investors talking about GOSS also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.